CN103073525B - Method for synthesizing (S)-(3,4-difluorophenyl)hexamethylene oxide - Google Patents

Method for synthesizing (S)-(3,4-difluorophenyl)hexamethylene oxide Download PDF

Info

Publication number
CN103073525B
CN103073525B CN201310043982.8A CN201310043982A CN103073525B CN 103073525 B CN103073525 B CN 103073525B CN 201310043982 A CN201310043982 A CN 201310043982A CN 103073525 B CN103073525 B CN 103073525B
Authority
CN
China
Prior art keywords
difluorophenyl
reaction
bromide
solvent
described step
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310043982.8A
Other languages
Chinese (zh)
Other versions
CN103073525A (en
Inventor
杨运旭
王爱志
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Science and Technology Beijing USTB
Original Assignee
University of Science and Technology Beijing USTB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Science and Technology Beijing USTB filed Critical University of Science and Technology Beijing USTB
Priority to CN201310043982.8A priority Critical patent/CN103073525B/en
Publication of CN103073525A publication Critical patent/CN103073525A/en
Application granted granted Critical
Publication of CN103073525B publication Critical patent/CN103073525B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a method for chiral synthesis of a (S)-(3,4-difluorophenyl)ethylene oxide intermediate. The method comprises the following steps: (1) performing Sharpless asymmetric dihydroxylation (AD) reaction on 3,4-difluorostyrene by taking t-BuOH/H2O as a solvent and AD-mix-alpha as an oxidant at the presence of methane sulfonamide to obtain (S)-(3,4-difluorophenyl)glycol; (2) mixing the (S)-(3,4-difluorophenyl)glycol and triethyl orthoacetate by a one-pot method, and condensing at a certain temperature to obtain a cyclic condensate intermediate; (3) mixing the cyclic condensate intermediate and a bromine reagent, reacting, adding water, separating out an organic layer, and treating to obtain a bromide intermediate; and (4) heating the bromide intermediate in the step (3) in an organic solvent at the presence of anhydrous potassium carbonate to react so as to obtain the (S)-(3,4-difluorophenyl)ethylene oxide target.

Description

A kind of method of synthesis preparation (S)-(3,4-difluorophenyl) oxepane
technical field:
The invention belongs to medicinal chemistry art, particularly a kind of chiral synthesize preparation ( s)-(3,4-difluorophenyl) method of polyethylene oxide intermediate.Crucial chiral raw material required when this chiral intermediate is ADZ6140 synthesis.
background technology:
ADZ6140 (ticagrelon) (as shown in Equation 1) is a kind of selectivity small molecules anticoagulation medicine.Be reversibly to act on P2Y 12acceptor, has stronger restraining effect to the platelet aggregation that adenosine diphosphate (ADP) (ADP) causes, and oral rear rapid-onset, obviously can improve the symptom of acute coronary.When building the structure of ADZ6140, ( 1R, 2S)-2-(3,4-difluorophenyl) cyclopropylamine (as shown in Equation 2) is a kind of chiral intermediate building block of key.The synthesis of this cyclopropylamine building block can use ( s)-3,4-difluorophenyl oxyethane are chiral starting materials.
formula (1)
formula (2)
Existing document [1] report, through ( s)-3,4 two-fluorophenyl polyethylene oxide intermediate, synthesize ( 1R, 2S)-2-(3,4-difluorophenyl) cyclopropylamine (Jean-Paul D; Koen P Marc R. WO 2008018822,2008-02-
14 and Masaru M.; Tadashi M; Kentaro T; Et al .WO 2008018823,2008-02-14 and Singh A K; Rao M N; Simpson J H; Et al, Org. Process Res. Dev. 2002,6,618-620. and Zhang H; Liu; Zhang L .Y; Et al .Bioorg. Med. Chem. Lett., 2012,22,3598-
3602.)。The core of these report route methods is with prochiral ketone precursor for raw material, through the reduction of prochiral ketone precursor under chiral induction agent exists, generates chiral alcohol derivative, then becomes ring to generate chiral epoxy compound.The chiral epoxy compound generated, Cyclopropanated through Wadsworth-Emmons, generate chiral cyclopropane sulfonamide derivatives, namely ( 1R, 2S)-2-(3,4-difluorophenyl) cyclopropylamine.These method routes are brief, and more direct during structure chiral centre, the optical purity of chiral material is higher.Its route methods is as being shown in accompanying drawing 1.
But, above-mentioned document synthesis ( s) chloro-1-(3, the 4-difluorophenyl of-2-) and ethanol time, still need use BH 3-Me 2s reductive agent, and ( s)-phenylbenzene Prolinol price is also more valuable.So, seek easy, reaction conditions gentle, chiral epoxy compound preparation method with low cost is of great significance.
summary of the invention:
The object of the invention is to propose a kind of ( s)-3, the new synthetic method of 4-difluorophenyl oxyethane, so that with it for chiral raw material, can synthesize the chiral intermediate building block (1R of ADZ6140 key under condition easy, that reaction conditions is gentle, with low cost, 2S)-2-(3,4-difluorophenyl) cyclopropylamine.
The present invention's proposition ( s) the synthetic method route of-3,4 difluorophenyl oxyethane is shown in accompanying drawing 2.
A kind of method of synthesis preparation (S)-3,4-fluorophenyl oxepane, it is characterized in that, synthesis step is as follows:
(1) under Toluidrin exists, with t-buOH/H 2o is solvent, and AD-mix-α is oxygenant, 3,4-difluorobenzene ethene is carried out to the AD reaction of Sharpless, generate ( s)-(3,4-difluorophenyl) ethylene glycol;
(2) incite somebody to action ( s)-(3,4-difluorophenyl) ethylene glycol " one kettle way " and triethly orthoacetate mixing, after reacting condensation under certain temperature, obtain ring-shaped condensate intermediate;
(3) by this ring-type shape condenses intermediate and bromide reagent mixing, reaction, adds water after completing, separates organic layer, treated bromo-derivative intermediate;
(4) step (3) gained bromide intermediate is in organic solvent, reacting by heating under Anhydrous potassium carbonate exists, obtain ( s)-(3,4-difluorophenyl) oxyethane.
Further, in described step (2), be by ( s)-(3,4-difluorophenyl) ethylene glycol first with triethly orthoacetate mixing, 10 DEG C--react at 100 DEG C, after reaction condensation, steam except excessive triethly orthoacetate, obtain ring-shaped condensate intermediate.
Further, described step (3) temperature of reaction is 10 DEG C--100 DEG C.
Further, described step (3) bromide reagent is acetyl bromide or bromotrimethylsilane.
Further, in described step (4), organic solvent used is methyl alcohol, ethanol, acetonitrile polar solvent.
The invention has the advantages that: reactions steps is short, reaction conditions is gentle, and products therefrom optical purity is high.
Accompanying drawing explanation
Fig. 1 be background technology Literature [1] ( s)-3,4-difluorophenyl ethylene oxide synthesis route maps.
Fig. 2 is method synthetic route chart of the present invention.
embodiment:
Embodiment 1:
(1) in reaction vessel, put into t-buOH/H 2o(10ml, v/v=1:1), AD-mix-α (2.0g), mix and blend, after 15 minutes, adds Toluidrin (158mg, 1.66mmol), then adds 3,4-difluorobenzene ethene (193mg, 1.38mmol) stirred at ambient temperature after stirring 15 minutes 24 hours.Add S-WAT 2.0g, continue stirring 1 hour, reaction mixture use water (30ml) processes, CH 2cl 2extraction (3 × 50ml), merges organic phase, dried over mgso.After removal of solvent under reduced pressure, obtain solids 216mg, yield 90 ﹪. 1H NMR (CDCl 3, 400MH Z ), δ:7.01-7.04(m,3H),4.57-4.59(m,1H),4.10-4.14(m,1H), 3.87-3.87(m,1H)。
(2) by (24.7g, 0.142mol) ( s)-(3,4-difluorophenyl) ethylene glycol, 70ml methylene dichloride drops in there-necked flask, and stirring and dissolving is warming up to 50 DEG C, adds 25.27 grams of triethly orthoacetates, and react after one hour, termination reaction, steams low-boiling point material, obtains 34 grams, ring-shaped condensate intermediate.Without purifying, be directly used in the next step, yield 100%.
34 grams, above-mentioned ring-shaped condensate intermediate is dissolved in 50ml methylene dichloride, after adding acetyl bromide 19.18 grams reaction 2h, 70ml water termination reaction is added in system, collected organic layer, water layer uses dichloromethane extraction secondary again, dried over mgso, obtains viscous material 35.6 grams, yield 90% after decompression removing methylene dichloride.I.e. bromo-derivative.
Above-mentioned bromo-derivative 35.6 grams, 70ml methyl alcohol, Anhydrous potassium carbonate, back flow reaction 1h, after completing reaction, decompression steams methyl alcohol, and resistates is dissolved in 70ml methylene dichloride, adds 30ml water, washes twice.Organic layer adds dried over mgso.Decompression steams methylene dichloride.Under reduced pressure distill, collect 70-73 degree fraction/10mmHg, obtain product 17.7 grams, yield 80%, namely ( s)-(3,4-difluorophenyl) oxyethane.
Embodiment 2:
(1) in reaction vessel, put into t-buOH/H 2o(5ml, v/v=1:1), AD-mix-α (1.0g),
Mix and blend, after 15 minutes, adds Toluidrin (79mg, 0.83mmol), then adds 3,4-difluorobenzene ethene (96.5mg, 0.69mmol) stirred at ambient temperature after stirring 15 minutes 24 hours.Add S-WAT 1.0g, continue stirring 1 hour, reaction mixture use water (15ml) processes, CH 2cl 2extraction (3 × 50ml), merges organic phase, dried over mgso.After removal of solvent under reduced pressure, obtain solids 104.4mg, yield 87 ﹪.
1H NMR (CDCl 3, 400MH Z ), δ:7.01-7.02(m,3H),4.56-4.60(m,1H),4.12-4.15(m,1H), 3.88-3.89(m,1H)。
(2) by (12.4g, 0.071mol) ( s)-(3,4-difluorophenyl) ethylene glycol, 35ml methylene dichloride drops in there-necked flask, and stirring and dissolving is warming up to 50 DEG C, adds 12.64 grams of triethly orthoacetates, and react after one hour, termination reaction, steams low-boiling point material, obtains 17 grams, ring-shaped condensate intermediate.Without purifying, be directly used in the next step, yield 100%.
17 grams, above-mentioned ring-shaped condensate intermediate is dissolved in 50ml methylene dichloride, after adding bromotrimethylsilane 10.86 grams reaction 2h, 35ml water termination reaction is added in system, collected organic layer, water layer uses dichloromethane extraction secondary again, dried over mgso, obtains viscous material 17.8 grams, yield 90% after decompression removing methylene dichloride.I.e. bromo-derivative.
Above-mentioned bromo-derivative 17.8 grams, 35ml ethanol, Anhydrous potassium carbonate, back flow reaction 1h, after completing reaction, decompression steams ethanol, and resistates is dissolved in 35ml methylene dichloride, adds 15ml water, washes twice.Organic layer adds dried over mgso.Decompression steams methylene dichloride.Under reduced pressure distill, collect 72-75 degree fraction/10mmHg, obtain product 8.9 grams, yield 80%, namely ( s)-(3,4-difluorophenyl) oxyethane.

Claims (4)

1. the method for synthesis preparation (S)-(3, a 4-difluorophenyl) oxepane, it is characterized in that, synthesis step is as follows:
(1) under Toluidrin exists, with t-BuOH/H 2o is solvent, and AD-mix-α is oxygenant, 3,4-difluorobenzene ethene is carried out to the AD reaction of Sharpless, generates (S) – (3,4-difluorophenyl) ethylene glycol;
(2) first (S)-(3,4-difluorophenyl) ethylene glycol is mixed with triethly orthoacetate, react at 10 DEG C-100 DEG C, after reaction condensation, steam except excessive triethly orthoacetate, obtain ring-shaped condensate intermediate;
(3) by this ring-shaped condensate intermediate and bromide reagent mixing, reaction, adds water after completing, separates organic layer, treated bromo-derivative intermediate;
(4) step (3) gained bromide intermediate in organic solvent, and reacting by heating under Anhydrous potassium carbonate exists, obtains (S)-(3,4-difluorophenyl) oxyethane.
2. the method according to right 1, is characterized in that: described step (3) temperature of reaction is 10 DEG C-100 DEG C.
3. the method according to right 1, is characterized in that: described step (3) bromide reagent is acetyl bromide or bromotrimethylsilane.
4. the method according to right 1, is characterized in that: in described step (4), and organic solvent used is methyl alcohol, ethanol, acetonitrile polar solvent.
CN201310043982.8A 2013-02-04 2013-02-04 Method for synthesizing (S)-(3,4-difluorophenyl)hexamethylene oxide Expired - Fee Related CN103073525B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310043982.8A CN103073525B (en) 2013-02-04 2013-02-04 Method for synthesizing (S)-(3,4-difluorophenyl)hexamethylene oxide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310043982.8A CN103073525B (en) 2013-02-04 2013-02-04 Method for synthesizing (S)-(3,4-difluorophenyl)hexamethylene oxide

Publications (2)

Publication Number Publication Date
CN103073525A CN103073525A (en) 2013-05-01
CN103073525B true CN103073525B (en) 2015-01-28

Family

ID=48150244

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310043982.8A Expired - Fee Related CN103073525B (en) 2013-02-04 2013-02-04 Method for synthesizing (S)-(3,4-difluorophenyl)hexamethylene oxide

Country Status (1)

Country Link
CN (1) CN103073525B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105671099A (en) * 2016-01-26 2016-06-15 中国科学院成都生物研究所 Method for preparing optical pure difluorophenyl ethylene oxide
CN115710158A (en) * 2021-08-23 2023-02-24 凯特立斯(深圳)科技有限公司 Method for preparing ticagrelor intermediate through asymmetric catalysis
CN115894496A (en) * 2021-09-30 2023-04-04 上海贝美医药科技有限公司 Preparation method of ticagrelor and intermediate thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101495444A (en) * 2006-08-05 2009-07-29 阿斯利康(瑞典)有限公司 A process for the preparation of optically active cyclopropylamines
CN101495442A (en) * 2006-08-05 2009-07-29 阿斯利康(瑞典)有限公司 Chemical process for preparation of aromatic cyclopropane esters and amides
WO2012001531A2 (en) * 2010-06-30 2012-01-05 Actavis Group Ptc Ehf Novel processes for the preparation of phenylcyclopropylamine derivatives and use thereof for preparing ticagrelor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101495444A (en) * 2006-08-05 2009-07-29 阿斯利康(瑞典)有限公司 A process for the preparation of optically active cyclopropylamines
CN101495442A (en) * 2006-08-05 2009-07-29 阿斯利康(瑞典)有限公司 Chemical process for preparation of aromatic cyclopropane esters and amides
WO2012001531A2 (en) * 2010-06-30 2012-01-05 Actavis Group Ptc Ehf Novel processes for the preparation of phenylcyclopropylamine derivatives and use thereof for preparing ticagrelor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
用 Sharpless 不对称双羟化反应合成手性 β-氨基醇;柳文敏 等;《有机化学》;20061231;第26卷(第3期);341-345 *

Also Published As

Publication number Publication date
CN103073525A (en) 2013-05-01

Similar Documents

Publication Publication Date Title
JP5395908B2 (en) Process for producing 4- (1-hydroxy-1-methylethyl) -2-propylimidazole-5-carboxylic acid ester
CN103073525B (en) Method for synthesizing (S)-(3,4-difluorophenyl)hexamethylene oxide
CN113214129A (en) Method for iodination/sulfonylation reaction of 1, 6-diene compound initiated by sulfonyl free radical
CN104844593A (en) Synthetic method for Apixaban drug intermediate
CN109535120B (en) Preparation method of 7-substituted-3, 4,4, 7-tetrahydrocyclobutane coumarin-5-ketone
CN114736151B (en) Preparation method of Pa Luo Weide key intermediate and structural formula of compound
CN108997377B (en) Preparation method of E-type 7-ATCA
CN106518758A (en) Preparation method of Betrixaban intermediate N-(5-chloro-2-pyridyl)-2-(4-cyanobenzeneformamido)-5-metoxybenzamide
CN113024479B (en) Preparation method of clomazone
CN103804414A (en) Intermediate compound for preparing rosuvastatin calcium and method for preparing rosuvastatin calcium from rosuvastatin calcium
CN103755657B (en) A kind of preparation method of Rivaroxaban intermediate
CN105330525A (en) Preparation method of 7-hydroxy-1-indanone
CN108727323B (en) Method for catalytically synthesizing trifluoromethyl substituted homoisoflavone compound by using N-heterocyclic carbene
CN102850270A (en) Method for preparing hydroxy substituted-3,4-dihydro-2(1H)-quinolinone compound by one-pot method
CN108358866B (en) Preparation method of febuxostat intermediate and application of febuxostat intermediate in preparation of febuxostat
CN107721917B (en) Green synthesis method of polysubstituted nicotinate compound
Chaumont-Olive et al. Total synthesis of spiromastilactone A
CN104292222A (en) Novel synthetic method of tebipenem pivoxil side chain
CN104987302B (en) N, N diethyl formic acid 4 halogenated methyl 3,5 xylenol ester compounds and preparation method thereof
CN103833717A (en) Synthetic method of nebivolol
CN105601640B (en) A kind of N- tertbutyloxycarbonyls -7-(Amine methyl)The synthetic method of -6- oxa- -2- spiral shells [4.5] decane
JP4157361B2 (en) Method for producing 9-spirofluorene compound
CN108997340B (en) Synthetic method of 5-bromo-7-azaindole
CN113372235B (en) Process for preparing 1-amino-2-phenylcyclopropanecarboxylic acids
CN113416142B (en) Preparation method of 5-ALA intermediate 5-bromolevulinate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150128

Termination date: 20210204